Gabelli & Co Investment Advisers’s Achillion Pharmaceuticals ACHN Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-291,050	Closed	-$1.75M	–	225
2019 Q4	$1.75M	Buy	+291,050	New	+$1.68M	0.2%	80

Gabelli & Co Investment Advisers's ACHN Position: Q1 2020 in Review

Gabelli & Co Investment Advisers sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 291,050 shares — an estimated $1.75M sold.

Gabelli & Co Investment Advisers first reported a position in ACHN in Q4 2019 and held it in 1 quarter. The position peaked at $1.75M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

Gabelli & Co Investment Advisers reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 291,050 Achillion Pharmaceuticals shares in Q1 2020, an estimated $1.75M.
Gabelli & Co Investment Advisers first reported a position in Achillion Pharmaceuticals in Q4 2019 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Achillion Pharmaceuticals position peaked at $1.75M in Q4 2019.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2020, filed 14 May 2020.